<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">36789492</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2547</StartPage><EndPage>2556</EndPage><MedlinePgn>2547-2556</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awad046</ELocationID><Abstract><AbstractText>Valosin-containing protein (VCP) is a hexameric ATPase associated with diverse cellular activities. Genetic mutations in VCP are associated with several forms of muscular and neuronal degeneration, including amyotrophic lateral sclerosis (ALS). Moreover, VCP mediates UV-induced proteolysis of RNA polymerase II (RNAPII), but little is known about the effects of VCP mutations on the transcriptional machinery. Here, we used silica particle-assisted chromatin enrichment and mass spectrometry to study proteins co-localized with RNAPII in precursor neurons differentiated from VCP-mutant or control induced pluripotent stem cells. Remarkably, we observed diminished RNAPII binding of proteins involved in transcription elongation and mRNA splicing in mutant cells. One of these is SART3, a recycling factor of the splicing machinery, whose knockdown leads to perturbed intron retention in several ALS-associated genes. Additional reduced proteins are RBM45, EIF5A and RNF220, mutations in which are associated with various neurodegenerative disorders and are linked to TDP-43 aggregation. Conversely, we observed increased RNAPII binding of heat shock proteins such as HSPB1. Together, these findings shed light on how transcription and splicing machinery are impaired by VCP mutations, which might contribute to aberrant alternative splicing and proteinopathy in neurodegeneration.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rafiee</LastName><ForeName>Mahmoud-Reza</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-1317-1162</Identifier><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohban</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davey</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ule</LastName><ForeName>Jernej</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute Centre, King's College London, London, SE5 9RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luscombe</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>The Francis Crick Institute, London NW1 1AT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Genetics Institute, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomics and Regulatory Systems Unit, Okinawa Institute of Science &amp; Technology Graduate University, Okinawa 904-0495, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FC001110</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FC001110</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>FC001110</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D012319">RNA Polymerase II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C416530">SART3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C467044">RBM45 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2023 Jun 1;146(6):2199-2200</RefSource><PMID Version="1">37258066</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012319" MajorTopicYN="N">RNA Polymerase II</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RNA polymerase II</Keyword><Keyword MajorTopicYN="N">SPACE</Keyword><Keyword MajorTopicYN="N">VCP</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>2</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36789492</ArticleId><ArticleId IdType="mid">EMS177491</ArticleId><ArticleId IdType="pmc">PMC7614746</ArticleId><ArticleId IdType="doi">10.1093/brain/awad046</ArticleId><ArticleId IdType="pii">7038566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ye Y, Tang WK, Zhang T, Xia D. A mighty &#x201c;protein extractor&#x201d; of the cell: Structure and function of the p97/CDC48 ATPase. Front Mol Biosci. 2017;4:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468458</ArticleId><ArticleId IdType="pubmed">28660197</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boom J, Meyer H. VCP/p97-Mediated unfolding as a principle in protein homeostasis and signaling. Mol Cell. 2018;69:182&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">29153394</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantuma NP, Bott LC. The ubiquitin&#x2013;proteasome system in neurodegenerative diseases: Precipitating factor, yet part of the solution. Front Mol Neurosci. 2014;7:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117186</ArticleId><ArticleId IdType="pubmed">25132814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochenova OV, Mukkavalli S, Raman M, Walter JC. Cooperative assembly of p97 complexes involved in replication termination. Nat Commun. 2022;13:6591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9633789</ArticleId><ArticleId IdType="pubmed">36329031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K. The proteasome: Overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:12&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524306</ArticleId><ArticleId IdType="pubmed">19145068</ArticleId></ArticleIdList></Reference><Reference><Citation>Steurer B, Janssens RC, Geijer ME, et al. . DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound pol II. Nat Commun. 2022;13:3624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9232492</ArticleId><ArticleId IdType="pubmed">35750669</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoi Y, Takahashi YH, Shah AP, et al. . SPT5 Stabilization of promoter-proximal RNA polymerase II. Mol Cell. 2021;81:4413&#x2013;4424 e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8687145</ArticleId><ArticleId IdType="pubmed">34480849</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarian E, Fiamingo G, Diamanti L, Palmieri I, Gagliardi S, Pansarasa O. The role of VCP mutations in the Spectrum of amyotrophic lateral sclerosis&#x2013;frontotemporal dementia. Front Neurol. 2022;13:841394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8902152</ArticleId><ArticleId IdType="pubmed">35273561</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, et al. . Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117:137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez FJ, Pratt GA, Van Nostrand EL, et al. . Protein&#x2013;RNA networks regulated by normal and ALS-associated mutant HNRNPA2B1 in the nervous system. Neuron. 2016;92:780&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123850</ArticleId><ArticleId IdType="pubmed">27773581</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B, La Cognata V, Sprovieri T, et al. . Alternative splicing of ALS genes: Misregulation and potential therapies. Cell Mol Neurobiol. 2020;40:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31385134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Wang Z, Hortobagyi T, et al. . Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. 2011;21:1572&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202275</ArticleId><ArticleId IdType="pubmed">21846794</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Patten SA. RNA dysregulation in amyotrophic lateral sclerosis. Front Genet. 2018;9:712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiee MR, Zagalak JA, Sidorov S, et al. . Chromatin-contact atlas reveals disorder-mediated protein interactions and moonlighting chromatin-associated RBPs. Nucleic Acids Res. 2021;49:13092&#x2013;13107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8682780</ArticleId><ArticleId IdType="pubmed">34871434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, et al. . Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19:1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludtmann MHR, Arber C, Bartolome F, et al. . Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. J Biol Chem. 2017;292:8907&#x2013;8917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5448124</ArticleId><ArticleId IdType="pubmed">28360103</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita K, Matsumura Y, Sato Y, et al. . A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">21460823</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, et al. . Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. Maxquant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, et al. . Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Hu E, Xu S, et al. . Clusterprofiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (N Y). 2021;2:100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand EL, Freese P, Pratt GA, et al. . A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583:711&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410833</ArticleId><ArticleId IdType="pubmed">32728246</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton R, Gao D, Thomas A, et al. . IRFinder: Assessing the impact of intron retention on mammalian gene expression. Genome Biol. 2017;18:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353968</ArticleId><ArticleId IdType="pubmed">28298237</ArticleId></ArticleIdList></Reference><Reference><Citation>Pessina F, Gioia U, Brandi O, et al. . DNA damage triggers a new phase in neurodegeneration. Trends Genet. 2021;37:337&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">33020022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Kodavati M, Britz GW, Hegde ML. DNA damage and repair deficiency in ALS/FTD-associated neurodegeneration: From molecular mechanisms to therapeutic implication. Front Mol Neurosci. 2021;14:784361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8716463</ArticleId><ArticleId IdType="pubmed">34975400</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, et al. . C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017;20:1225&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Guo W, Mitra J, et al. . Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in amyotrophic lateral sclerosis. Nat Commun. 2018;9:3683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero EN, Mitra J, Wang H, et al. . Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4&#x2013;DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28:3161&#x2013;3162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6867871</ArticleId><ArticleId IdType="pubmed">31504503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC, et al. . Longitudinal analysis reveals high prevalence of Epstein&#x2013;Barr virus associated with multiple sclerosis. Science. 2022;375:296&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M, Li Y, Bowser R. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases. Acta Neuropathol Commun. 2020;8:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318465</ArticleId><ArticleId IdType="pubmed">32586379</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Dillen L, Baradaran-Heravi Y, et al. . Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;156:105421.</Citation><ArticleIdList><ArticleId IdType="pubmed">34118419</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashiko T, Sakashita E, Kasashima K, et al. . Developmentally regulated RNA-binding protein 1 (Drb1)/RNA-binding motif protein 45 (RBM45), a nuclear-cytoplasmic trafficking protein, forms TAR DNA-binding protein 43 (TDP-43)-mediated cytoplasmic aggregates. J Biol Chem. 2016;291:14996&#x2013;15007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4946918</ArticleId><ArticleId IdType="pubmed">27226551</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M, Riascos D, Kovalik T, et al. . The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol. 2012;124:717&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472056</ArticleId><ArticleId IdType="pubmed">22993125</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeltzer S, Quadri Z, Miller A, et al. . Hypusination of Eif5a regulates cytoplasmic TDP-43 aggregation and accumulation in a stress-induced cellular model. Biochim Biophys Acta Mol Basis Dis. 2021;1867:165939.</Citation><ArticleIdList><ArticleId IdType="pubmed">32882370</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Kar RK, Banka S, Ziegler A, Chung WK. Post-translational formation of hypusine in eIF5A: Implications in human neurodevelopment. Amino Acids. 2022;54:485&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9117371</ArticleId><ArticleId IdType="pubmed">34273022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P, Li Y, Wang H, Mao B. Haploinsufficiency of the TDP43 ubiquitin E3 ligase RNF220 leads to ALS-like motor neuron defects in the mouse. J Mol Cell Biol. 2021;13:374&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373269</ArticleId><ArticleId IdType="pubmed">33386850</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannone B, Tsiaras WG, de la Monte S, et al. . GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling. Hum Mol Genet. 2009;18:4629&#x2013;4639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773276</ArticleId><ArticleId IdType="pubmed">19744960</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng YL, Wang X, An R, et al. . Epitranscriptomic m(6)A regulation of axon regeneration in the adult mammalian nervous system. Neuron. 2018;97:313&#x2013;325 e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5777326</ArticleId><ArticleId IdType="pubmed">29346752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawauchi J, Inoue M, Fukuda M, et al. . Transcriptional properties of mammalian elongin A and its role in stress response. J Biol Chem. 2013;288:24302&#x2013;24315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750133</ArticleId><ArticleId IdType="pubmed">23828199</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E, Lin C, Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 2011;25:661&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3070929</ArticleId><ArticleId IdType="pubmed">21460034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vendredy L, Adriaenssens E, Timmerman V. Small heat shock proteins in neurodegenerative diseases. Cell Stress Chaperones. 2020;25:679&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332613</ArticleId><ArticleId IdType="pubmed">32323160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavel M, Imarisio S, Menzies FM, et al. . CCT complex restricts neuropathogenic protein aggregation via autophagy. Nat Commun. 2016;7:13821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5155164</ArticleId><ArticleId IdType="pubmed">27929117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaitsuka T, Tomizawa K, Matsushita M. Transformation of eEF1Bdelta into heat-shock response transcription factor by alternative splicing. EMBO Rep. 2011;12:673&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128969</ArticleId><ArticleId IdType="pubmed">21597468</ArticleId></ArticleIdList></Reference><Reference><Citation>Novotny I, Malinova A, Stejskalova E, et al. . SART3-dependent accumulation of incomplete spliceosomal snRNPs in Cajal bodies. Cell Rep. 2015;10:429&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">25600876</ArticleId></ArticleIdList></Reference><Reference><Citation>Report of the World Health Organization . Active ageing: A policy framework. Aging Male. 2002;5:1&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">12040973</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R, Tyzack GE, Hall CE, et al. . Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat Commun. 2018;9:2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S, Khurana S, Vats A, et al. . Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol Neurobiol. 2022;59:1502&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pubmed">34997540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Lee G, Pontifex CS, et al. . Multisystem proteinopathy due to VCP mutations: A review of clinical heterogeneity and genetic diagnosis. Genes (Basel). 2022;13:963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222868</ArticleId><ArticleId IdType="pubmed">35741724</ArticleId></ArticleIdList></Reference><Reference><Citation>Aso T, Lane WS, Conaway JW, Conaway RC. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science. 1995;269:1439&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">7660129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardehali MB, Damle M, Perea-Resa C, Blower MD, Kingston RE. Elongin A associates with actively transcribed genes and modulates enhancer RNA levels with limited impact on transcription elongation rate in vivo. J Biol Chem. 2021;296:100202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948453</ArticleId><ArticleId IdType="pubmed">33334895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong N, Kim H, Zhou Y, et al. . Pre-mRNA splicing is facilitated by an optimal RNA polymerase II elongation rate. Genes Dev. 2014;28:2663&#x2013;2676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248296</ArticleId><ArticleId IdType="pubmed">25452276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng JT, Lin CX, Fang ZY, Li HD. Intron retention as a mode for RNA-seq data analysis. Front Genet. 2020;11:586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358572</ArticleId><ArticleId IdType="pubmed">32733531</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Birsa N, Milioto C, et al. . FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020;48:6889&#x2013;6905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, Orie VK, Williams T, et al. . TDP-43 proteinopathies: A new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H, Lim LZ, Wei Y, Song J. TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA. Proc Natl Acad Sci U S A. 2014;111:18619&#x2013;18624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284588</ArticleId><ArticleId IdType="pubmed">25503365</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: New insights into pathogenic mechanisms. Nat Rev Genet. 2009;10:769&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P, Mao B. The many faces of the E3 ubiquitin ligase, RNF220, in neural development and beyond. Dev Growth Differ. 2022;64:98&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">34716995</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriaenssens E, Geuens T, Baets J, Echaniz-Laguna A, Timmerman V. Novel insights in the disease biology of mutant small heat shock proteins in neuromuscular diseases. Brain. 2017;140:2541&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">28969372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Hu J, Arogundade OA, et al. . Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nat Cell Biol. 2022;24:1378&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9872726</ArticleId><ArticleId IdType="pubmed">36075972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>